PCV58 COSTS OF CORONARY ARTERY DISEASE (CAD) IN POLAND von Banasiak, W, Jaworski, R, Pachocki, R

Volltext

Effects of Almitrine Bismesylate on Arterial Blood Gases in Patients with Chronic Obstructive Pulmonary Disease and Moderate Hypoxaemia: A Multicentre, Randomised, Double-Blind, Pl... von Górecka, D., Śliwiński, P., Pałasiewicz, G., Pachocki, R., Zieliński, J.

Volltext

PCN28 SHOULD FOTEMUSTINE BE USED AS THE FIRST LINE TREATMENT von Faluta, T, Czech, M, Pachocki, R

Volltext

Anti-Ischaemic Efficacy and Tolerability of Trimetazidine in Elderly Patients with Angina Pectoris: A Sub-Study from TRIMPOL-1 (Trimetazidine in Poland) von Szwed, H., Sadowski, Z., Pachocki, R., Domzal-Bochenska, M., Malczewska, B., Jedrzejczyk, B., Kania, G., Powala, D., Hulok, W., Kowalisko, A., Kulczuga-Kaczmarek, K., Grzelak-Szczepanska, H., Michalak, J., Dabrowski, R., Tykarski, A.

Volltext

PCV58 THE ROLE OF ECONOMIC FACTORS IN THERAPEUTIC DECISION MAKING CONCERNING TREATMENT OF CORONARY ARTERY DISEASE IN POLAND von Banasiak, W, Jaworski, R, Czech, M, Pachocki, R

Volltext

PCV45 COST OF CHRONIC VENOUS INSUFFICIENCY (CVI) IN POLAND von Bartminski, W, Faluta, T, Czech, M, Pachocki, R

Volltext

PHP20 PROPER DRUG MANAGEMENT IN PHARMACY—THE ROLE OF PHARMACOECONOMICSAS PERCEIVED BY POLISH PHARMACISTS von Czech, M, Turczynski, R, Pachocki, R

Volltext

PHP14 ECONOMIC ASPECTS OF INDIVIDUAL TREATMENT IN POLAND—OUT-PATIENT VIEWPOINT von Czech, M, Horoszewska, M, Pachocki, R

Volltext

PCV56 EVALUATION OF COSTS RELATED TO HYPERTENSION IN PATIENTS WITH CONCOMITANT DISEASES IN POLAND von Hermanowski, T, Jaworski, R, Czech, M, Pachocki, R

Volltext

PCV55 EVALUATION OF COSTS RELATED TO HYPERTENSION IN PATIENTS WITH UNCONTROLLED HYPERTENSION IN POLAND von Hermanowski, T, Jaworski, R, Czech, M, Pachocki, R

Volltext

PRS7 COST-EFFECTIVENESS OF FENSPIRIDE IN ADULTS WITH CHRONIC BRONCHITIS EXACERBATIONS IN POLAND von Pirozynski, M, Bartminski, W, Czech, M, Faluta, T, Pachocki, R

Volltext

PHP3 PERSPECTIVES AND BARRIERS IN THE DEVELOPMENT OF PHARMACOECONOMICS AND ITS APPLICATIONS IN POLANDPRELIMINARY RESULTS OF A SURVEY von M, Czech, Hermanowski, T, Pachocki, R

Volltext

PCVI8 COSTS OF HYPERTENSION IN THE ELDERLY IN COMPARISON WITH PATIENTS UNDER 65 IN POLAND von Hermanowski, T, Jaworski, R, Czech, M, Pachocki, R

Volltext

PCV20 COST EFFECTIVENESS OF ANTIHYPERTENSIVE MONO-THERAPYWITH PERINDOPRIL OR ENALAPRIL IN ELDERLY PATIENTS FROM THE THIRD PARTY PAYER PERSPECTIVE von Hermanowski, T, Jaworski, R, Czech, M, Pachocki, R

Volltext

PCVI7 COSTS OF HYPERTENSION IN POLAND MEASURED FROM THE THIRD PARTY PAYER PERSPECTIVE IN COMPARISON WITH THE SOCIETAL PERSPECTIVE von Hermanowski, T, Jaworski, R, Czech, M, Pachocki, R

Volltext

PCV19 TWO METHODS OF ASSESSING COSTS OF PHARMACOLOGICAL TREATMENT ASSOCIATED WITH CHRONIC VENOUS INSUFFICIENCY (CVI) IN POLAND von Czech, M, Faluta, T, Pachocki, R

Volltext

PWH3 PULSED OESTROGEN THERAPY WITH INTRANASAL 17-B OESTRADIOL IMPROVES WOMEN'S QUALITY OF LIFE IN THE EARLY POSTMENOPAUSAL PERIOD von Szamatowicz, M, Jaworski, R, Bartminski, W, Czech, M, Pachocki, R

Volltext

PCV15: CHRONIC VENOUS INSUFFICENCY (CVI) IN POLAND—A COST OF ILLNESS STUDY von Czech, M, Faluta, T, Pachocki, R

Volltext

PDB43 SHOULD WE LOOK FOR A NEWAPPROACH IN DIABETES MELLITUS (DM) MANAGEMENT? IS IT A COST-EFFECTIVE STRATEGY IN THE POLISH SETTING? von Sieradzki, J, Kinalska, I, Niewada, M, Faluta, V, Czech, M, Latek, M, Wilkins, A, Szczepanski, M, Pachocki, R

Volltext

PCV23 PHARMACOECONOMIC COMPARISON OF THE ANTIHYPERTENSIVE TREATMENT WITH TWO DIFFERENT ANGIOTENSINE CONVERTING ENZYME INHIBITORS: PERINDOPRIL AND ENALAPRIL von Hermanowski, T, Jaworski, R, Czech, M, Pachocki, R

Volltext